Cognitive Processing + Self-Compassion Therapies for PTSD
(HRT Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to evaluate how two therapies, Cognitive Processing Therapy (CPT) and Self-Compassion Therapy (SC), reduce symptoms of PTSD and feelings of mental contamination (a sense of dirtiness linked to trauma) in individuals who have experienced sexual trauma. The study will test various sequences of these therapies to determine which is most effective. It seeks participants with PTSD from sexual trauma who frequently feel mentally contaminated. Participants should maintain stability on any current medications and agree to avoid other trauma treatments during the study. As an unphased trial, this study provides a unique opportunity to explore innovative therapy sequences that could significantly enhance mental health outcomes.
Will I have to stop taking my current medications?
You can continue taking your current medications if they are psychotropic (affecting the mind) and you have been on a stable dose for at least 4 weeks before the study. You must also keep the dosage stable during the study.
Is there any evidence suggesting that this trial's treatments are likely to be safe?
Research has shown that Cognitive Processing Therapy (CPT) is a well-known and safe treatment for PTSD. One study found that 14.7% of patients experienced minor issues during treatment, but these were not serious. Experts recommend CPT as a reliable therapy for PTSD, and it has been widely used with positive results, especially among military and veteran patients.
Self-Compassion Therapy (SC) is a newer method that involves treating oneself with kindness and understanding. Although less research exists on SC, early studies suggest it helps reduce PTSD symptoms and the feelings of shame and guilt that often accompany it. Importantly, no major safety concerns have been reported with SC.
Both therapies aim to help people with PTSD, and evidence suggests they are generally safe and well-tolerated by participants.12345Why are researchers excited about this trial?
Researchers are excited about these therapies for PTSD because they combine Cognitive Processing Therapy (CPT) with Self-Compassion Therapy (SC), offering a unique approach to treatment. Unlike traditional PTSD treatments, which often focus solely on cognitive restructuring, this approach integrates self-kindness and emotional resilience, potentially enhancing overall emotional healing. The trial explores different sequences of these therapies to determine the most effective order, offering insights into personalized PTSD treatment strategies that could improve outcomes for individuals struggling with this condition.
What evidence suggests that this trial's treatments could be effective for PTSD?
This trial will explore the effects of combining Cognitive Processing Therapy (CPT) and Self-Compassion Therapy (SC) for PTSD. Research has shown that CPT effectively reduces symptoms like depression and improves overall well-being, with many studies supporting its effectiveness and long-lasting benefits. In contrast, SC has shown mixed results in reducing PTSD symptoms, but some research suggests it can help with trauma-related feelings, such as shame and guilt. Although SC may not have as much support as CPT, it shows promise, particularly for addressing feelings of mental contamination. Participants in this trial will receive both therapies in different sequences, potentially offering a more comprehensive approach to reducing PTSD symptoms and mental contamination.13678
Who Is on the Research Team?
Christal L Badour, PhD
Principal Investigator
University of Kentucky
Are You a Good Fit for This Trial?
This trial is for adults over 18 who speak English, have experienced sexual trauma, and are currently dealing with PTSD and feelings of internal 'dirtiness' or mental contamination. They must not be starting new trauma treatments during the study, should maintain a stable dose if on psychotropic meds, and meet certain criteria for PTSD severity.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Baseline
Participants undergo a baseline assessment period with weekly measures of PTSD symptoms and mental contamination
Treatment
Participants receive either 12 sessions of Cognitive Processing Therapy (CPT) or 6 sessions of Self-Compassion Therapy (SC), followed by a 3-week return to baseline and then the alternate therapy
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- Cognitive Processing Therapy
- Self-Compassion Therapy
Cognitive Processing Therapy is already approved in United States, European Union for the following indications:
- Posttraumatic Stress Disorder (PTSD)
- Posttraumatic Stress Disorder (PTSD)
Find a Clinic Near You
Who Is Running the Clinical Trial?
Christal L Badour
Lead Sponsor